Markman Advisors
Patent Valuation, Monetization and Investments

Blog

Markman Advisors Patent Blog

by Zachary Silbersher

Posts tagged Roivant
Why did Acuitas bring a patent lawsuit against Arbutus?

The LNP patent battle lines are being drawn. In the past several weeks, Arbutus has sued Moderna, Alnylam has suedboth Moderna and Pfizer, and in the latest, Acuitas Therapeutics has sued Arbutus and Genevant. What can we expect from the Acuitas lawsuit?

Read More
Markman AdvisorsArbutus, Arbutus Biopharma, Genevant, Roivant, Moderna, Pfizer, BioNTech, LNP, lipid, lipid nanoparticle, cationic lipid, lawsuit, patent, license, IPR, royalty, Acuitas, Acuitas Therapeutics, Alnylam, Zachary Silbersher, Silbersher, ABUS, MRNA, PFE Comment